198 related articles for article (PubMed ID: 20207453)
21. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.
Srinath P; Rao PN; Knaus EE; Suresh MR
Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system.
Santagati A; Granata G; Marrazzo A; Santagati M
Arch Pharm (Weinheim); 2003 Sep; 336(9):429-35. PubMed ID: 14528491
[TBL] [Abstract][Full Text] [Related]
23. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.
Mohammed KO; Nissan YM
Chem Biol Drug Des; 2014 Oct; 84(4):473-88. PubMed ID: 24720475
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of dithiolethiones as novel cyclooxygenase inhibitors.
Zanatta SD; Manallack DT; Jarrott B; Williams SJ
Bioorg Med Chem Lett; 2009 Jan; 19(2):459-61. PubMed ID: 19056264
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors.
Patel MV; Bell R; Majest S; Henry R; Kolasa T
J Org Chem; 2004 Oct; 69(21):7058-65. PubMed ID: 15471453
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological activity and molecular modeling studies of novel COX-1 inhibitors.
Martić M; Tatić I; Marković S; Kujundzić N; Kostrun S
Eur J Med Chem; 2004 Feb; 39(2):141-51. PubMed ID: 14987823
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents.
Selvam C; Jachak SM; Thilagavathi R; Chakraborti AK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1793-7. PubMed ID: 15780608
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
[TBL] [Abstract][Full Text] [Related]
32. Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors.
Uddin MJ; Rao PN; Knaus EE
Bioorg Med Chem Lett; 2004 Apr; 14(8):1953-6. PubMed ID: 15050635
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
[TBL] [Abstract][Full Text] [Related]
34. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
[TBL] [Abstract][Full Text] [Related]
36. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
[TBL] [Abstract][Full Text] [Related]
37. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and evaluation of tetrahydropyran based COX-1/-2 inhibitors.
Singh P; Bhardwaj A; Kaur S; Kumar S
Eur J Med Chem; 2009 Mar; 44(3):1278-87. PubMed ID: 18835505
[TBL] [Abstract][Full Text] [Related]
39. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses.
Marsik P; Kokoska L; Landa P; Nepovim A; Soudek P; Vanek T
Planta Med; 2005 Aug; 71(8):739-42. PubMed ID: 16142638
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles.
Handler N; Jaeger W; Kuen-Krismer B; Erker T
Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]